JERUSALEM, May 15, 2026 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI), ("Scinai" or the "Company") a biopharmaceutical company focused on inflammation and immunology, today announced that members of its leadership team will lead a strategic roundtable discussion at the 7th...
Hence then, the article about scinai immunotherapeutics to lead strategic roundtable discussion on oral therapies and the future of biologics at the 7th dermatology drug development summit europe was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Scinai Immunotherapeutics to Lead Strategic Roundtable Discussion on Oral Therapies and the Future of Biologics at the 7th Dermatology Drug Development Summit Europe )
Also on site :
- Placer County deputies search for man who fired shots at law enforcement, rammed patrol car
- Sweet Magnolias Stars And Creator Say Goodbye To Canceled Netflix Drama: 'I Hope Serenity Will Always Have A Place In Your Heart'
- 01F Group Announces Investment in DANA, Indonesia's Leading Digital Financial Company, Reinforcing Long-Term Confidence in Asia's Fintech Opportunity